Kevin Dysart, MD Kevin Dysart, MD, is the Associate Medical Director of the Newborn/Infant Intensive Care Unit and an attending neonatologist with the Division of Neonatology at Children's Hospital of Philadelphia. Locations: Main Campus; CHOP Newborn Care at the Hospital of the University of Pennsylvania Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Background Dr. Kevin Dysart is a neonatologist and Associate Medical Director of the Newborn/Infant Intensive Care Unit at Children's Hospital of Philadelphia (CHOP). He received his undergraduate degree in chemistry from Villanova University, Villanova, PA, and earned his medical degree from Drexel University, Philadelphia, PA. Dr. Dysart completed his internship, residency and fellowship at Thomas Jefferson University Hospital, where he trained in pediatrics and neonatal/perinatal medicine. Dr. Dysart's interests include newborn lung disease in both term and preterm infants and therapies directed at improving outcomes. He also has an interest in the outcomes of newborns and the ability of diagnostic tests to predict the presence or absence of diseases, as well as the future of newborns affected by a variety of conditions. Education and Training Medical SchoolMD - Hahnemann University, Philadelphia, PA InternshipPediatrics - Thomas Jefferson University and duPont Hospital for Children, Philadelphia, PA ResidencyPediatrics - Thomas Jefferson University and duPont Hospital for Children, Philadelphia, PA FellowshipNeonatal and Perinatal Medicine - Thomas Jefferson University and Christiana Care Health System, Wilmington, DE Board CertificationAmerican Board of PediatricsNeonatal-Perinatal Medicine Titles and Academic Titles Attending NeonatologistAssociate Medical Director of the Newborn/Infant Intensive Care UnitAssociate Professor of Clinical Pediatrics, Perelman School of Medicine at the University of Pennsylvania Departments and Services Newborn and Infant Chronic Lung Disease Program Division of NeonatologyNewborn/Infant Intensive Care Unit (N/IICU) Publications Papers2018 Flannery DD, Dysart K, Cook A, Greenspan J, Aghai ZH, Jensen EA. Association Between Early Antibiotic Exposure and Bronchopulmonary Dysplasia or Death. J Perinatol, Epub ahead of print, June 13, 2018. Jensen EA, Foglia EE, Dysart KC, Simmons RA, Aghai ZH, Cook A, Greenspan JS, DeMauro SB. Adverse effects of small for gestational age differ by gestational week among very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2018 May 5. pii: fetalneonatal-2017-314171. doi: 10.1136/archdischild-2017-314171. [Epub ahead of print] 2017 Jensen EA, Foglia EE, Dysart KC, Aghai ZH, Cook A, Greenspan JS, DeMauro SB. Car Seat Tolerance Screening in the Neonaal Intensive Care Unit: Failure Rates, Risk Factors, and Adverse Outcomes. J Pediatr. 2017 Dec 18. pii: S0022-3476(17)31503-2. doi: 10.1016/j.jpeds.2017.11.010. [Epub ahead of print] Partridge EA, Davey MG, Hornick MA, McGovern PE, Mejaddam AY, Vrecenak JD, Mesas-Burgos C, Olive A, Caskey RC, Weiland TR, Han J, Schupper AJ, Connelly JT, Dysart KC, Rychik J, Hedrick HL, Peranteau WH, Flake AW. Corrigendum: An extra-uterine system to physiologically support the extreme premature lamb. Nat Commun. 2017 May 23;8:15794. Doi: 10.1038/ncomms15794. Emily A. Partridge, Marcus G. Davey, Matthew A. Hornick, Patrick E. McGovern, Ali Y. Mejaddam, Jesse D. Vrecenak, Carmen Mesas-Burgos, Aliza Olive, Robert C. Caskey, Theodore R. Weiland III, Jiancheng Han, James T. Connelly, Kevin C. Dysart, Alexander J. Schupper, Jack Rychik, Holly L. Hedrick, William H. Peranteau, and Alan W. Flake. “An extra-uterine physiologic support system for the extreme premature lamb.” Nature Communications. Published online April 25, 2017. Tkach EK, White AM, Dysart KC, Waber B, Nawab US, Zhang H, Jensen EA. Comparison of Intact Parathyroid Hormone, Alkaline Phosphatase, Phosphate Levels for Diagnosing Severe Metabolic Bone Disease in Infants with Severe Bronchopulmonary Dysplasia. Am J Perinatol. 2017 Apr 21. doi: 10.1055/s-0037-1602419. [Epub ahead of print] Jensen EA, Dysart KC, Gantz MG, Carper B, Higgins RD, Keszler M, Laughon MM, Poindexter BB, Stoll BJ, Walsh MC, Schmidt B, For the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association between use of prophylactic indomethacin and the risk for bronchopulmonary dysplasia in extremely preterm infants. J Pediatr. 2017;186:34-40 Tramper J, Zhang H, Foglia EE, Dysart KC, Padula MA, Sullivan KV, Jensen EA. The association between positive tracheal aspirate cultures and adverse pulmonary outcomes in preterm infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2017;34(1):96-104. Partridge EA, Davey MG, Hornick MA, McGovern PE, Mejaddam AY, Vrecenak JD, Mesas-Burgos C, Olive A, Caskey RC, Weiland TR, Han J, Schupper AJ, Connelly JT, Dysart KC, Rychik J, Hedrick HL, Peranteau WH, Flake AW. An extra-uterine system to physiologically support the extreme premature lamb. Nat Commun. 2017 Apr 25;8:15112. 2015 Bamat NA, Tharakan SJ, Connelly JT, Hedrick HL, Lorch SA, Rintoul NE, Williams SB, Dysart KC. Venoarterial extracorporeal life support for neonatal respiratory failure: indications and impact on mortality. ASAIO J. 2016 Dec 13. [Epub ahead of print] Foglia EE, DeMauro SB, Dysart K, Kirpalani H. When has enough evidence accumulated to change neonatal practice? Semin Fetal Neonatal Med. 2015 Dec;20(6):424-30. doi: 10.1016/j.siny.2015.09.003. Epub 2015 Oct 4. Jensen EA, DeMauro SB, Kornhauser M, Aghai ZH, Greenspan JS, Dysart KC. Effects of multiple ventilation courses and duration of mechanical ventilation on respiratory outcomes in extremely low-birth-weight infants. JAMA Pediatr. 2015;169(11):1011-7. 2014 Shankaran S, Laptook AR, Pappas A, McDonald SA, Das A, Tyson JE, Poindexter BB, Schibler K, Bell EF, Heyne RJ, Pedroza C, Bara R, Van Meurs KP, Grisby C, Huitema CM, Garg M, Ehrenkranz RA, Shepherd EG, Chalak LF, Hamrick SE, Khan AM, Reynolds AM, Laughon MM, Truog WE, Dysart KC, Carlo WA, Walsh MC, Watterberg KL, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA. 2014 Dec 24-31;312(24):2629-39. doi: 10.1001/jama.2014.16058. Read the abstract. Taha D, Kirkby S, Nawab U, Dysart KC, Genen L, Greenspan JS, Aghai ZH. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J Matern Fetal Neonatal Med. 2014 Feb 17. [Epub ahead of print] Read the abstract. 2012 Dysart, Kevin C et al. “Amplitude-Integrated Electroencephalography: a Runaway Horse?." The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 39.3 (2012): 267-268. Print. 2011 Anagnostis, Elena A et al. "Formulation Buprenorphine for Sublingual Use in Neonates," The journal of pediatric pharmacology and therapeutics: JPPT: the official journal of PPAG 16.4 (2011): 281-284. Oshodi A, Dysart K, Cook A, Rodriguez E, Zhu Y, Shaffer TH, et al. Airway injury resulting from repeated endotracheal intubation: Possible prevention strategies. Pediatr Crit Care Med. 2011 Jan;12(1):e34-9. Cited in PubMed; PMID 20375754. Read the abstract 2010 Frizzola M, Miller TL, Rodriguez ME, Zhu Y, Rojas J, Hesek A, et al. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol. 2011 Jan;46(1):67-74. Epub 2010 Nov 23. Cited in PubMed; PMID 21171186. Read the abstract Zisk JL, Genen LH, Kirkby S, Webb D, Greenspan J, Dysart K. Do premature female infants really do better than their male counterparts? Am J Perinatol. Epub 2010 Nov 2. Cited in PubMed; PMID 21046537. Read the abstract Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction. Epub 2010 Oct 6. doi: 10.1111/j.1360-0443.2010.03170.x. Cited in PubMed; PMID 20925688. Read the abstract Kumar MA, Jain A, Dechant VE, Saito T, Rafael T, Aizawa H, et al. Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol. 2010 Jul;67(7):884-7. Cited in PubMed; PMID 20625099. Read the article Seligman NS, Almario CV, Hayes EJ, Dysart KC, Berghella V, Baxter JK. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatr. 2010 Sep;157(3):428-33, 433.e1. Epub 2010 May 15. Cited in PubMed; PMID 20472252. Read the abstract 2009 Almario CV, Seligman NS, Dysart KC, Berghella V, Baxter JK. Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol. 2009 Sep;201(3):326.e1-6. Epub 2009 Jul 24. Cited in PubMed; PMID 19631928. Read the abstract Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respir Med. 2009 Oct;103(10):1400-5. Epub 2009 May 21. Cited in PubMed; PMID 19467849. Read the abstract Chong E, Dysart KC, Chidekel A, Locke R, Shaffer TH, Miller TL. Heat shock protein 70 secretion by neonatal tracheal tissue during mechanical ventilation: association with indices of tissue function and modeling. Pediatr Res. 2009 Apr;65(4):387-91. Cited in PubMed; PMID 19127221. Read the article Editorial and Academic Positions Editorial positions 2013, Ad Hoc Reviewer, American Journal of Perinatology 2013, Ad Hoc Reviewer, Pediatrics 2012, Cochrane Review Board 2011, Ad Hoc Reviewer, Journal of Pediatric Intensive Care Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.